Inventor · disambiguated record
Michael Sabio
Also filed as: SABIO MICHAEL L · SABIO MICHAEL LLOYD
5 granted patents·11 pending applications·5 citations·filing 2001–2018
68Inventor score
Top patents by PatentIndex Score
16 records- 0164US7183304B2Heterocyclic compounds and methods of useNOVARTIS AG·Filed 2002·Granted Feb 27, 2007·3 cites·19 claims
- 0260US6833367B2Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumorsNOVARTIS AC·Filed 2002·Granted Dec 21, 2004·2 cites·16 claims
- 0359US2009118160A1Heterocyclic compounds and methods of useBACH ANDREW THOMAS·Filed 2009·Application pending·0 cites
- 0454US2007135502A1Heterocyclic compounds and methods of useBACH ANDREW T·Filed 2007·Application pending·0 cites
- 0552US2011230497A1Biologically active amidesLUNDBECK & CO AS H·Filed 2009·Application pending·0 cites
- 0651US7148218B2Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumorsNOVARTIS AG·Filed 2004·Granted Dec 12, 2006·0 cites·6 claims
- 0750US7192980B2Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumorsNOVARTIS AG·Filed 2004·Granted Mar 20, 2007·0 cites·19 claims
- 0849US6972292B2Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumorsNOVARTIS AG·Filed 2002·Granted Dec 6, 2005·0 cites·14 claims
- 0949US2004077549A1Inhibitors of the E2F-1/cyclin interaction for cancer therapyFiled 2003·Application pending·0 cites
- 1049US2011251171A1Heterocyclic compounds and methods of useBACH ANDREW THOMAS·Filed 2011·Application pending·0 cites
- 1148US2004053849A1Inhibitors of the E2F-1/cyclin interaction for cancer therapyFiled 2003·Application pending·0 cites
- 1245US2007060582A11,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseasesFINK CYNTHIA A·Filed 2004·Application pending·0 cites
- 1343US2019134056A1K-ras mutations and antagonistsSTEVENS INSTITUTE OF TECHNOLOGY·Filed 2018·Application pending·0 cites
- 1443US2006293340A12-Aminopyrimidine derivatives as raf kinase inhibitorsNOVARTIS AG·Filed 2004·Application pending·0 cites
- 1537US2002142966A1Inhibitors of the E2F-1/cyclin interaction for cancer therapyFiled 2001·Application pending·0 cites
- 1633US2002091142A1Alpha4beta1 and alpha4beta7 integrin inhibitorsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →